Eye health issues that are making the news - Autumn 2022.
Caffeine metabolite may slow child myopia progression in children
Short-sightedness was observed to progress more slowly in children taking a compound derived from coffee, according to a new study.
Researchers found that taking 7-methylxanthine (7-MX) – a caffeine metabolite licensed as a myopia treatment in Denmark since 2009 – was associated with smaller increases in axial elongation and refractive error.
Sign in to continue
Not already a member of the College?
Start enjoying the benefits of College membership today. Take a look at what the College can offer you and view our membership categories and rates.
The College and Eye Research Group Oxford are collaborating to bring you a webinar on Monday 24 June, on how optometrists can get involved in research.